Skip to main content
SpringerLink
Log in

The nocebo effect and patient perceptions of biosimilars in inflammatory bowel disease

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Boone NW, Liu L, Romberg-camps MJ et al (2018) The nocebo effect challenges the non-medical infliximab switch in practice. Eur J Clin Pharmacol 74(5):655–661

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Jacobs I, Singh E, Sewell KL, Al-Sabbagh A, Shane LG (2016) Patient attitudes and understanding about biosimilars: an international cross-sectional survey. Patient Prefer Adherence 10:937–948

    Article  PubMed  PubMed Central  Google Scholar 

  3. van Overbeeke E, de Beleyr B, de Hoon J, Westhovens R, Huys I (2017) Perception of originator biologics and biosimilars: a survey among Belgian rheumatoid arthritis patients and rheumatologists. BioDrugs 31(5):447–459

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, NYU Langone Health, New York, NY, USA

    David Pineles & Brian Bosworth

  2. Division of Gastroenterology, Bellevue Hospital, New York, NY, USA

    Lisa Malter

  3. Division of Gastroenterology, VA New York Harbor Healthcare System, Manhattan Medical Center, New York, NY, USA

    Peter S. Liang

  4. Inflammatory Bowel Disease Center, Division of Gastroenterology, NYU Langone Health, New York, NY, USA

    Amy Arsuaga, Brian Bosworth, David P. Hudesman & Shannon Chang

Authors
  1. David Pineles
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lisa Malter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter S. Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amy Arsuaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Brian Bosworth
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David P. Hudesman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shannon Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shannon Chang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pineles, D., Malter, L., Liang, P.S. et al. The nocebo effect and patient perceptions of biosimilars in inflammatory bowel disease. Eur J Clin Pharmacol 74, 1361–1362 (2018). https://doi.org/10.1007/s00228-018-2492-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-018-2492-7

Search

Navigation